Deafness in a Double Merle Australian Shepherd
Deafness in double merle Australian Shepherds, genetic risks, early identification signs, and practical communication strategies for owners.
Deafness in double merle Australian Shepherds, genetic risks, early identification signs, and practical communication strategies for owners.
Double merle Australian Shepherd puppies face severe health challenges like deafness and blindness caused by complex breeding genetics.
Double merle Australian Shepherds face severe deafness, blindness, and health defects caused by breeding two merle parents together.
The merle gene acts as a modifier that dilutes base coat colors, creating distinct patterns and blue or marbled eyes in Australian Shepherds.
Genetic testing helps Australian Shepherd owners communicate MDR1 status to veterinarians and prevent severe drug reactions.
An Australian Shepherd carrier MDR1 gene mutation result means altered drug sensitivity requiring careful medication management.
Australian Shepherd MDR1 testing identifies genetic mutations that cause severe reactions to common veterinary medications and drugs.
Standard heartworm doses remain safe for Australian Shepherds with the MDR1 mutation because preventatives use extremely low microgram levels.
Genetic testing for the MDR1 mutation helps Australian Shepherd owners identify dangerous drugs like ivermectin and loperamide.
The MDR1 gene mutation in Australian Shepherds disrupts the blood brain barrier, allowing harmful medications to enter the brain.